Clinical Trial: A Randomized Trial Evaluating a mRNA VLP Vaccine's Immunogenicity and Safety for COVID-19
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-label, Randomized, Active-Controlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 Vaccine (ARTEMIS-C)
Brief Summary:
The purpose of this study is to characterize the safety and immunogenicity of AZD9838 when administered as a single dose vaccination against SARS-CoV-2 in adults.
Read more